Kathleen M Morrow

Summary

Affiliation: Rhode Island Hospital
Country: USA

Publications

  1. ncbi request reprint Understanding the psychosocial needs of HIV-positive women: a qualitative study
    K Morrow
    Center for Behavioral and Preventive Medicine, Brown Medical School, and The Miriam Hospital, Providence, RI 02903, USA
    Psychosomatics 42:497-503. 2001
  2. pmc Clinical evaluation of microbicide formulations
    Kathleen M Morrow
    The Miriam Hospital and the Warren Alpert Medical School of Brown University, CBPM, CORO West, 1 Hoppin Street, Providence, RI 02903, USA
    Antiviral Res 88:S40-6. 2010
  3. pmc Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, Warren Alpert Medical School of Brown University, The Miriam Hospital, One Hoppin Street, Providence, RI 02903, USA
    Health Psychol 26:777-86. 2007
  4. pmc Assessing microbicide acceptability: a comprehensive and integrated approach
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, Department of Psychiatry and Human Behavior, The Miriam Hospital and the Warren Alpert Medical School of Brown University, CORO West, One Hoppin Street, Providence, RI, USA
    AIDS Behav 12:272-83. 2008
  5. doi request reprint Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability
    Kathleen M Morrow
    The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    Qual Health Res 21:987-99. 2011
  6. pmc The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital Brown Medical School, CORO West, Providence, RI 02903, USA
    AIDS Behav 11:586-95. 2007
  7. pmc Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Providence, RI 02903, USA
    J Acquir Immune Defic Syndr 45:93-101. 2007
  8. ncbi request reprint HIV, STD and hepatitis prevention among women in methadone maintenance: a qualitative and quantitative needs assessment
    K Morrow
    Centers for Behavioral and Preventive Medicine, Brown Medical School and The Miriam Hospital, Providence, Rhode Island 02903, USA
    AIDS Care 16:426-33. 2004
  9. ncbi request reprint The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial
    Kathleen Morrow
    Centers for Behavioral and Preventive Medicine, Brown Medical School, and The Miriam Hospital, Lifespan Academic Medical Center, Providence, Rhode Island 02903, USA
    J Womens Health (Larchmt) 12:655-66. 2003
  10. doi request reprint HIV, STD, and hepatitis risk behaviors of young men before and after incarceration
    K M Morrow
    The Miriam Hospital, Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Centers for Behavioral and Preventive Medicine, Providence, USA
    AIDS Care 21:235-43. 2009

Research Grants

Detail Information

Publications20

  1. ncbi request reprint Understanding the psychosocial needs of HIV-positive women: a qualitative study
    K Morrow
    Center for Behavioral and Preventive Medicine, Brown Medical School, and The Miriam Hospital, Providence, RI 02903, USA
    Psychosomatics 42:497-503. 2001
    ..These results support ongoing development of psychosocial support groups for women with HIV disease and further exploration of the efficacy of group models for the diverse subgroups of women with HIV/AIDS...
  2. pmc Clinical evaluation of microbicide formulations
    Kathleen M Morrow
    The Miriam Hospital and the Warren Alpert Medical School of Brown University, CBPM, CORO West, 1 Hoppin Street, Providence, RI 02903, USA
    Antiviral Res 88:S40-6. 2010
    ..This article forms part of a special supplement covering two presentations on clinical evaluation of microbicides from the symposium on "Recent Trends in Microbicide Formulations" held on 25 and 26 January 2010, Arlington, VA...
  3. pmc Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, Warren Alpert Medical School of Brown University, The Miriam Hospital, One Hoppin Street, Providence, RI 02903, USA
    Health Psychol 26:777-86. 2007
    ..To investigate women's willingness to use vaginal microbicides to reduce/prevent HIV infection, using measures grounded in the individual, behavioral, and social contexts of sex...
  4. pmc Assessing microbicide acceptability: a comprehensive and integrated approach
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, Department of Psychiatry and Human Behavior, The Miriam Hospital and the Warren Alpert Medical School of Brown University, CORO West, One Hoppin Street, Providence, RI, USA
    AIDS Behav 12:272-83. 2008
    ....
  5. doi request reprint Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability
    Kathleen M Morrow
    The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    Qual Health Res 21:987-99. 2011
    ..This integrated mixed method design was critical to the development of this psychometrically validated behavioral measure, and could serve as a model for future measure development...
  6. pmc The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital Brown Medical School, CORO West, Providence, RI 02903, USA
    AIDS Behav 11:586-95. 2007
    ..Non-proportional quota sampling is a feasible option for ensuring adequate representation of sample characteristics in microbicide research, but this goal should be weighed against cost and staff burden...
  7. pmc Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties
    Kathleen M Morrow
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Providence, RI 02903, USA
    J Acquir Immune Defic Syndr 45:93-101. 2007
    ..Understanding Product Characteristics that users find most acceptable and determining who will use which type of product are key to optimizing use effectiveness...
  8. ncbi request reprint HIV, STD and hepatitis prevention among women in methadone maintenance: a qualitative and quantitative needs assessment
    K Morrow
    Centers for Behavioral and Preventive Medicine, Brown Medical School and The Miriam Hospital, Providence, Rhode Island 02903, USA
    AIDS Care 16:426-33. 2004
    ..The development of such programming would require partnering with the target population and their service providers to develop feasible and effective interventions...
  9. ncbi request reprint The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial
    Kathleen Morrow
    Centers for Behavioral and Preventive Medicine, Brown Medical School, and The Miriam Hospital, Lifespan Academic Medical Center, Providence, Rhode Island 02903, USA
    J Womens Health (Larchmt) 12:655-66. 2003
    ..In this study, the acceptability of an investigational microbicide, PRO 2000 Gel (Indevus Pharmaceuticals, Inc., Lexington, MA), was assessed, and women's opinions about microbicides and their potential for real world use were gathered...
  10. doi request reprint HIV, STD, and hepatitis risk behaviors of young men before and after incarceration
    K M Morrow
    The Miriam Hospital, Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Centers for Behavioral and Preventive Medicine, Providence, USA
    AIDS Care 21:235-43. 2009
    ..These young men are at sexual risk of HIV, STD and hepatitis infection after release from prison. Interventions are needed to prevent this population from acquiring and transmitting HIV, STD and hepatitis...
  11. pmc Yoga as a complementary treatment for smoking cessation in women
    Beth C Bock
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI 02903, USA
    J Womens Health (Larchmt) 21:240-8. 2012
    ..Studies outside the realm of smoking cessation have shown that yoga practice also reduces perceived stress and negative affect...
  12. doi request reprint Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study
    Rochelle K Rosen
    The Miriam Hospital, Providence, Rhode Island 02903, USA
    J Womens Health (Larchmt) 17:383-92. 2008
    ..The impact of acceptability factors on use of the gel and the relationship between qualitative and quantitative acceptability data are explored...
  13. doi request reprint Measuring self-efficacy to use vaginal microbicides: the Microbicide Use Self-Efficacy instrument
    Joseph L Fava
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI 02906, USA
    Sex Health 10:339-47. 2013
    ..The MUSE instrument can be a useful tool in capturing the multidimensional nature of self-efficacy to use microbicides among diverse populations of women. ..
  14. pmc "Set it and Forget it": Women's Perceptions and Opinions of Long-Acting Topical Vaginal Gels
    Jacob J Van Den Berg
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA
    AIDS Behav 18:862-70. 2014
    ..Long-acting vaginal gels capable of protecting against HIV/STIs will be a viable option among potential users, with dosing frequency being an important factor in willingness to use. ..
  15. doi request reprint User preferences for a text message-based smoking cessation intervention
    Beth C Bock
    Alpert Medical School of Brown University, Providence, RI 02903, USA
    Health Educ Behav 40:152-9. 2013
    ....
  16. pmc Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties
    Kathleen M Morrow
    1 Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island
    AIDS Res Hum Retroviruses 30:78-91. 2014
    ..By understanding the impact of USPEs on that process, formulation development can optimize both drug delivery and adherence. ..
  17. pmc Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study
    Beth C Bock
    Centers for Behavioral and Preventive Medicine, Alpert School of Medicine at Brown University, The Miriam Hospital, Providence, RI 02903, USA
    BMC Complement Altern Med 10:14. 2010
    ..Yoga practice also includes regulation of breathing and focused attention, both of which may enhance stress reduction and improve mood and well-being and may improve cessation outcomes...
  18. pmc A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV
    Michelle A Lally
    Department of Medicine, Miriam Hospital Warren Alpert Medical School of Brown University, Providence, Rhode Island 02906, USA
    AIDS Patient Care STDS 22:53-64. 2008
    ..These methods should include strategies that minimize stigma and facilitate accessibility of health care...
  19. ncbi request reprint Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates
    David Wyatt Seal
    Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, 2071 North Summit Avenue, Milwaukee, WI 53202, USA
    AIDS Behav 12:27-40. 2008
    ..Findings document the occurrence of substance use and sexual behavior among incarcerated men, and highlight the need for continued research into the context of these behaviors...
  20. ncbi request reprint Perspectives related to the potential use of vaginal microbicides among drug-involved women: focus groups in three cities in the United States and Puerto Rico
    Theresa H Mason
    Abt Associates Inc, Cambridge, Massachusetts, USA
    AIDS Behav 7:339-51. 2003
    ..Focus groups also provided insight into how aspects of different women's sexual lives, including partner type, might influence the issues that would concern them if and when they tried out new microbicidal products in the future...

Research Grants7

  1. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2001
    ..abstract_text> ..
  2. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2002
    ..abstract_text> ..
  3. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2002
    ..abstract_text> ..
  4. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2003
    ..abstract_text> ..
  5. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2004
    ..abstract_text> ..
  6. A Contextual Model of Microbicide Acceptability
    Kathleen Morrow; Fiscal Year: 2005
    ..abstract_text> ..
  7. Linking Biophysical Functions of Microbicides to User Perception & Acceptability
    Kathleen Morrow; Fiscal Year: 2007
    ..In sum, this work will contribute methodology leading to rational design of microbicide formulations that co-optimize vaginal distribution and retention with user acceptability. ..